PRESOL | 66 | Purchase of Versant Hepatitis C Virus (HCV) Amplification and Genotyping LiPA Kits and Versant LiPA Consumables to measure incident and chronic infection of HCV with Versant System.

FBO DAILY ISSUE OF AUGUST 07, 2009 FBO #2813
SOLICITATION NOTICE

66 -- Purchase of Versant Hepatitis C Virus (HCV) Amplification and Genotyping LiPA Kits and Versant LiPA Consumables to measure incident and chronic infection of HCV with Versant System.

Notice Date: 8/5/2009
Notice Type: Presolicitation
NAICS: 334516 — Analytical Laboratory Instrument Manufacturing
Contracting Office: Department of Health and Human Services, Centers for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, Georgia, 30341-4146
ZIP Code: 30341-4146
Solicitation Number: SNR74040
Archive Date: 9/3/2009
Point of Contact: Sherrie N. Randall, Phone: 7704882866, Betty B Vannoy, Phone: 7704882891
E-Mail Address: iom2@cdc.gov, bbv9@cdc.gov
(iom2@cdc.gov, bbv9@cdc.gov)
Small Business Set-Aside: N/A
Description: NOTICE OF INTENT TO SOLE SOURCE: The Centers for Disease Control and Prevention (CDC) announces its intention to negotiate and issue a sole source award for the purchase of Versant HCV Amplification and Genotyping LiPA Kits and Versant LiPA Consumables listed below with Siemens Healthcare Diagnostics Inc, Norwood, MA. LiPA Kits and Consumables: LiPA Scan Reading Template Sheets, 25/bx LiPA Strip Tray, 25/bx Versant HCV Control 2.0 kit LiPA Versant HCV Amplification 2.0 kit LiPA Versant Genotype 2.0 Assay kit LiPA The anticipated delivery date will be 30 days from the award date. Siemens Healthcare Diagnostics Inc., is the only source to provide Versant HCV Amplification and Genotyping LiPA Kits and Versant LiPA Consumables compatible with the Versant System within the critical timeframe deemed necessary by CDC. CDC intends to negotiate this requirement under the authority of FAR 13.106-1(b)(1). The sole source procurement will be awarded as a simplified acquisition in accordance with FAR Part 12 and FAR Subpart 13 procedures. This notice of intent is not a request for competitive proposals. A determination to compete this procurement based on a response to this notice is solely within the discretion of the Government. Interested parties who believe they possess the capabilities to satisfy this requirement should submit a capability statement demonstrating their abilities to meet this requirement. All responses should be received by August 19, at 9 AM, Eastern Standard Time (EST). All responses must be in writing and can be sent via email to iom2@cdc.gov. No phone calls will be accepted.
Web Link: FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/CDCP/PGOA/SNR74040/listing.html)
Place of Performance: Address: Norwood, Massachusetts, 02062, United States; Zip Code: 02062
Record: SN01900071-W 20090807/090806000755-50e0438073c7be1aed64353c25eb1999 (fbodaily.com)
Source: FedBizOpps Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's FBO Daily Index Page |

Loren Data's SAM Daily™

66 -- Purchase of Versant Hepatitis C Virus (HCV) Amplification and Genotyping LiPA Kits and Versant LiPA Consumables to measure incident and chronic infection of HCV with Versant System.